RD
Robert Dow
Pfizer Global Research and Development, Harvard University, California Institute of Technology, Hope College
0000-0002-3045-5503
Employment
-
Pfizer Global Research and Development Associate Research Fellow1985 - Present
Education
-
Harvard University Ph.D.1983 - 1985
-
California Institute of Technology M.A.1980 - 1983
-
Hope College A.B.1976 - 1980
Projects & Funding
Projects & funding information is unavailable.
Publications (46)
- Identification and characterization of selective inhibitors of Nav1.9 voltage dependent sodium channels Save
- Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting Save
- 2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety Save
- Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic Treatment Save
- MAP4K4 Is a Threonine Kinase That Phosphorylates FARP1 Save
- Undesired versus designed enzymatic cleavage of linkers for liver targeting Save
- Defining the key pharmacophore elements of PF-04620110: Discovery of a potent, orally-active, neutral DGAT-1 inhibitor Save
- Erratum: Defining the key pharmacophore elements of PF-04620110: Discovery of a potent, orally-active, neutral DGAT-1 inhibitor (Bioorganic and Medicinal Chemistry (2013) 21 (5081-5097)) Save
- High specificity in response of the sodium-dependent multivitamin transporter to derivatives of pantothenic acid Save
- Medicinal chemistry design principles for liver targeting through OATP transporters Save